Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa
A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in...
- Autores:
-
Munita, Jose M.
Aitken, Samuel L.
Miller, William R.
Perez, Federico
Rosa, Rossana
Shimose, Luis A.
Lichtenberger, Paola N.
Abbo, Lilian M.
Jain, Rupali
Nigo, Masayuki
Wanger, Audrey
Araos, Rafael
Tran, Truc T.
Adachi, Javier
Rakita, Robert
Shelburne, Samuel
Bonomo, Robert A.
Arias, Cesar A.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/3679
- Acceso en línea:
- http://hdl.handle.net/20.500.12495/3679
https://doi.org/10.1093/cid/cix014
https://repositorio.unbosque.edu.co
- Palabra clave:
- Ceftolozane
Carbapenem resistant
P. aeruginosa
Multidrug resistant
- Rights
- openAccess
- License
- Acceso abierto
| id |
UNBOSQUE2_80346d3dcb0dc0c3ee4bb2825b166f62 |
|---|---|
| oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/3679 |
| network_acronym_str |
UNBOSQUE2 |
| network_name_str |
Repositorio U. El Bosque |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| dc.title.translated.spa.fl_str_mv |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| title |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| spellingShingle |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa Ceftolozane Carbapenem resistant P. aeruginosa Multidrug resistant |
| title_short |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| title_full |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| title_fullStr |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| title_full_unstemmed |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| title_sort |
Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosa |
| dc.creator.fl_str_mv |
Munita, Jose M. Aitken, Samuel L. Miller, William R. Perez, Federico Rosa, Rossana Shimose, Luis A. Lichtenberger, Paola N. Abbo, Lilian M. Jain, Rupali Nigo, Masayuki Wanger, Audrey Araos, Rafael Tran, Truc T. Adachi, Javier Rakita, Robert Shelburne, Samuel Bonomo, Robert A. Arias, Cesar A. |
| dc.contributor.author.none.fl_str_mv |
Munita, Jose M. Aitken, Samuel L. Miller, William R. Perez, Federico Rosa, Rossana Shimose, Luis A. Lichtenberger, Paola N. Abbo, Lilian M. Jain, Rupali Nigo, Masayuki Wanger, Audrey Araos, Rafael Tran, Truc T. Adachi, Javier Rakita, Robert Shelburne, Samuel Bonomo, Robert A. Arias, Cesar A. |
| dc.subject.keywords.spa.fl_str_mv |
Ceftolozane Carbapenem resistant P. aeruginosa Multidrug resistant |
| topic |
Ceftolozane Carbapenem resistant P. aeruginosa Multidrug resistant |
| description |
A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in all cases where isolates demonstrated ceftolozane-tazobactam minimum inhibitory concentrations ≥8 μg/mL. |
| publishDate |
2020 |
| dc.date.accessioned.none.fl_str_mv |
2020-08-05T13:34:42Z |
| dc.date.available.none.fl_str_mv |
2020-08-05T13:34:42Z |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.local.none.fl_str_mv |
Artículo de revista |
| dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
http://purl.org/coar/resource_type/c_6501 |
| dc.identifier.issn.none.fl_str_mv |
1537-6591 |
| dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12495/3679 |
| dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1093/cid/cix014 |
| dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
| dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
| dc.identifier.repourl.none.fl_str_mv |
https://repositorio.unbosque.edu.co |
| identifier_str_mv |
1537-6591 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque |
| url |
http://hdl.handle.net/20.500.12495/3679 https://doi.org/10.1093/cid/cix014 https://repositorio.unbosque.edu.co |
| dc.language.iso.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.ispartofseries.spa.fl_str_mv |
Clinical Infectious Diseases, 1537-6591, Vol. 65, Nro. 1, 2017, p. 158–161 |
| dc.relation.uri.none.fl_str_mv |
https://academic.oup.com/cid/article/65/1/158/3069333 |
| dc.rights.local.spa.fl_str_mv |
Acceso abierto |
| dc.rights.accessrights.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto |
| dc.rights.creativecommons.none.fl_str_mv |
2017-03-14 |
| rights_invalid_str_mv |
Acceso abierto http://purl.org/coar/access_right/c_abf2 2017-03-14 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.none.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Oxford University Press |
| dc.publisher.journal.spa.fl_str_mv |
Clinical Infectious Diseases |
| institution |
Universidad El Bosque |
| bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/57c151bd-7bd1-4dcb-83ba-f94e43c0fc88/download https://repositorio.unbosque.edu.co/bitstreams/958475c1-8316-415e-8482-a1b60214ade3/download https://repositorio.unbosque.edu.co/bitstreams/29553d38-4ec4-4d35-bed8-68f9c26a4fa1/download https://repositorio.unbosque.edu.co/bitstreams/2f439bd1-ea52-47a6-9c81-6813039a4a93/download https://repositorio.unbosque.edu.co/bitstreams/5d871a34-318c-462b-b064-c183f8f61058/download |
| bitstream.checksum.fl_str_mv |
a97c5a71060781d799d5000917ac40d7 8a4605be74aa9ea9d79846c1fba20a33 7210a811635d1799e7c05fee5d259be7 be37d4ad09313865c101050bd0c50479 94980af1c8e49a6cbb5c7235f23f06bc |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
| repository.mail.fl_str_mv |
bibliotecas@biteca.com |
| _version_ |
1814100823087513600 |
| spelling |
Munita, Jose M.Aitken, Samuel L.Miller, William R.Perez, FedericoRosa, RossanaShimose, Luis A.Lichtenberger, Paola N.Abbo, Lilian M.Jain, RupaliNigo, MasayukiWanger, AudreyAraos, RafaelTran, Truc T.Adachi, JavierRakita, RobertShelburne, SamuelBonomo, Robert A.Arias, Cesar A.2020-08-05T13:34:42Z2020-08-05T13:34:42Z1537-6591http://hdl.handle.net/20.500.12495/3679https://doi.org/10.1093/cid/cix014instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengOxford University PressClinical Infectious DiseasesClinical Infectious Diseases, 1537-6591, Vol. 65, Nro. 1, 2017, p. 158–161https://academic.oup.com/cid/article/65/1/158/3069333Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosaMulticenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant pseudomonas aeruginosaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85CeftolozaneCarbapenem resistantP. aeruginosaMultidrug resistantA multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in all cases where isolates demonstrated ceftolozane-tazobactam minimum inhibitory concentrations ≥8 μg/mL.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2017-03-14ORIGINALMunita, Jose M..pdfMunita, Jose M..pdfapplication/pdf152229https://repositorio.unbosque.edu.co/bitstreams/57c151bd-7bd1-4dcb-83ba-f94e43c0fc88/downloada97c5a71060781d799d5000917ac40d7MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/958475c1-8316-415e-8482-a1b60214ade3/download8a4605be74aa9ea9d79846c1fba20a33MD52THUMBNAILMunita, Jose M. .pdf.jpgMunita, Jose M. .pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/29553d38-4ec4-4d35-bed8-68f9c26a4fa1/download7210a811635d1799e7c05fee5d259be7MD53Munita, Jose M..pdf.jpgMunita, Jose M..pdf.jpgIM Thumbnailimage/jpeg10756https://repositorio.unbosque.edu.co/bitstreams/2f439bd1-ea52-47a6-9c81-6813039a4a93/downloadbe37d4ad09313865c101050bd0c50479MD54TEXTMunita, Jose M..pdf.txtMunita, Jose M..pdf.txtExtracted texttext/plain20923https://repositorio.unbosque.edu.co/bitstreams/5d871a34-318c-462b-b064-c183f8f61058/download94980af1c8e49a6cbb5c7235f23f06bcMD5520.500.12495/3679oai:repositorio.unbosque.edu.co:20.500.12495/36792024-02-07 10:02:59.983restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |